arginyl-glycyl-aspartic acid and galangin

arginyl-glycyl-aspartic acid has been researched along with galangin in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Bahramifar, A; Emameh, RZ; Ghorbani, M; Hajipour, H; Nouri, M; Taheri, RA	1

Other Studies

1 other study(ies) available for arginyl-glycyl-aspartic acid and galangin

Article	Year
Targeted nanostructured lipid carrier containing galangin as a promising adjuvant for improving cytotoxic effects of chemotherapeutic agents. Naunyn-Schmiedeberg's archives of pharmacology, 2021, Volume: 394, Issue:12 Topics: A549 Cells; Antibiotics, Antineoplastic; Apoptosis; Cell Line; Doxorubicin; Drug Carriers; Drug Delivery Systems; Drug Resistance, Neoplasm; Flavonoids; Gene Expression Regulation, Neoplastic; Humans; Lipids; Lung Neoplasms; Nanoparticles; Oligopeptides; Particle Size	2021

Article

Year

Targeted nanostructured lipid carrier containing galangin as a promising adjuvant for improving cytotoxic effects of chemotherapeutic agents.

Naunyn-Schmiedeberg's archives of pharmacology, 2021, Volume: 394, Issue:12

Topics: A549 Cells; Antibiotics, Antineoplastic; Apoptosis; Cell Line; Doxorubicin; Drug Carriers; Drug Delivery Systems; Drug Resistance, Neoplasm; Flavonoids; Gene Expression Regulation, Neoplastic; Humans; Lipids; Lung Neoplasms; Nanoparticles; Oligopeptides; Particle Size

2021